Important: The following data is for information purposes only. Please note that access to VAC drug benefits will vary depending upon an individual's eligibility and specific health needs. More Details
This information was posted August 29, 2012. Additions or revisions to the Formulary may have subsequently occurred.
Displaying 14041 - 14050 of 24215
Identification Number | Trade Name | Benefit Category |
---|---|---|
02336618 | NU-NAPRO-NA DS TAB 550MG | Standard Benefit for Eligible Clients |
02336669 | RATIO-MONTELUKAST (CHEWABLE TABLET) 4MG | Standard Benefit for Eligible Clients |
02336677 | RATIO-MONTELUKAST (CHEWABLE TABLET) 5MG | Standard Benefit for Eligible Clients |
02336685 | RATIO-MONTELUKAST TAB 10MG | Standard Benefit for Eligible Clients |
02336693 | NU-KETOROLAC OPH LIQ 0.5% | Standard Benefit for Eligible Clients |
02336707 | VIDAZA PWS 100MG / VIAL | Standard Benefit for Eligible Clients |
02336715 | APO-RIVASTIGMINE CAP 1.5MG | This is not a Standard Benefit. Special Authorization is required. |
02336723 | APO-RIVASTIGMINE CAP 3MG | This is not a Standard Benefit. Special Authorization is required. |
02336731 | APO-RIVASTIGMINE CAP 4.5MG | This is not a Standard Benefit. Special Authorization is required. |
02336758 | APO-RIVASTIGMINE CAP 6MG | This is not a Standard Benefit. Special Authorization is required. |
Displaying 14041 - 14050 of 24215